I’m not pleased they couldn’t do any direct Vision sales even with new E/M codes. I think Skincure sales have to be discounted somewhat from a valuation perspective; there must be a reason derm’s don’t want to buy direct.
Time will tell. If there is something special here with IORT, there will be a long runway. Until then, I have a few better ideas.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.